Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).

Véronique Phé Marc P Schneider Benoît PeyronnetNadim Abo YoussefLivio MordasiniEmmanuel Chartier-KastlerLucas M BachmannThomas M M Kessler

Published in: Neurourology and urodynamics (2019)

Preliminary data suggest that desmopressin might be effective for treating nocturia in patients with MS. However, adverse events are relatively common, the overall quality of evidence is low and the number of studied patients is very limited. Further studies with newer formulations of desmopressin are highly warranted.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
lower urinary tract symptoms
big data
benign prostatic hyperplasia
robot assisted
patient reported outcomes
machine learning
artificial intelligence